DGAP-News 1747 0 Kommentare MeVis Medical Solutions AG: Domination and profit and loss transfer agreement registered with the Commercial Register

DGAP-News: MeVis Medical Solutions AG / Key word(s): Miscellaneous
MeVis Medical Solutions AG: Domination and profit and loss transfer
agreement registered with the Commercial Register

23.10.2015 / 17:30

---------------------------------------------------------------------

Bremen, November 23, 2015 - The MeVis Medical Solutions AG announces today
that the domination and profit and loss transfer agreement concluded on
August 10, 2015 between the VMS Deutschland Holdings GmbH as the
controlling company and MeVis Medical Solutions AG as the controlled
company has been registered with the Commercial Register of the Bremen
Local Court on October 20, 2015 and has thus become legally effective. The
registration in the Commercial Register has been published by the Bremen
Local Court on October 21, 2015. The shareholders of the MeVis Medical
Solutions AG already approved the domination and profit and loss transfer
agreement with a large majority in the extraordinary general meeting on
September 29, 2015.

Under the domination and profit and loss transfer agreement and upon
request of each outside shareholder the VMS Deutschland Holdings GmbH is
obliged to acquire MeVis shares against a cash settlement payment in the
amount of EUR 19.77 per MeVis share.

Optionally, the VMS Deutschland Holdings GmbH guarantees the outside
shareholders of MeVis Medical Solutions AG, who chose not to accept the
settlement payment offer, for the duration of the domination and profit and
loss transfer agreement an annual compensation payment for each MeVis
Medical Solutions AG fiscal year and each registered share in MeVis Medical
Solutions AG, representing a pro rata amount of the share capital of EUR
1.00 per share, in the amount of EUR 1.13 gross / EUR 0.95 net.

---------------------------------------------------------------------

23.10.2015 Dissemination of a Corporate News, transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------

Language: English
Company: MeVis Medical Solutions AG
Caroline-Herschel-Str. 1
28359 Bremen
Germany
Phone: +49 421 224 95 0
Fax: +49 421 224 95 999
E-mail: ir@mevis.de
Internet: http://www.mevis.de
ISIN: DE000A0LBFE4
WKN: A0LBFE
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart

End of News DGAP News Service
---------------------------------------------------------------------
405179 23.10.2015